Improved prognosis of Pseudomonas aeruginosa bacteremia in 127 consecutive neutropenic patients with hematologic malignancies

International Journal of Infectious Diseases

Volumn 3, Issue 2, 1999, Pages 99-104

  Todeschini, Giuseppe ^a,b   Franchini, Massimo ^a   Tecchio, Cristina ^a   Meneghini, Vittorio ^a   Pizzolo, Giovanni ^a   Veneri, Dino ^a   Murari, Corrado ^a   Ricetti, Maria M ^a   Perona, Giuseppe ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Bacteremia; Neutropenia; Pseudomonas aeruginosa

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; PENICILLIN G;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL PNEUMONIA; CHILD; CONTROLLED STUDY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NEUTROPENIA; PROGNOSIS; PSEUDOMONAS AERUGINOSA; SEPTIC SHOCK;

EID: 0032422593     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1201-9712(99)90017-6     Document Type: Article

References (40)

1. Chang HY, Rodriguez V, Narboni G, Bodey GP, Luna MA, Freireich EJ. Causes of death in adults with acute leukemia. Medicine 1976; 55:259-268.
2. Estey EH, Keating MJ, McCredie KB, et al. Causes of initial remission induction failure in acute myelogenous leukemia. Blood 1982; 60:309-325.
3. Singer SC, Kaplan MM, Armstrong D. Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases. Am J Med 1977; 62:731-742.
4. McCabe WR, Jackson GG. Gram-negative bacteremia: I. Etiology and ecology. Arch Intern Med 1962; 110:847-855.
5. Kreger BE, Craven DE, McCabe WR. Gram-negative bacteremia: IV Re-evaluation of clinical features and treatment in 612 patients. Am J Med 1980; 68:344-355.
6. Whimbey E, Kiehn TE, Brannon P, Blevins A, Armstrong D. Bacteremia and fungemia in patients with neoplastic disease. Am J Med 1987; 82:723-730.
7. Bisbe J, Gatell JM, Puig J, et al. Pseudomonas aeruginosa bacteremia: univariate and multivariate analyses of factors influencing the prognosis in 133 episodes. Rev Infect Dis 1988; 10:629-635.
8. Gallagher PG, Watanakunakorn C. Pseudomonas bacteremia in a community teaching hospital 1980-84. Rev Infect Dis 1989; 11:846-852.
9. Todeschini G, Vinante F, Benini F, Perini A, Pasini F, Cetto GL. Gram-negative septicemia in patients with hematologic malignancies. Eur J Cancer 1984; 20:327-331.
10. Fishmann LS, Armstromg D. Pseudomonas aeruginosa bacteremia in patients with neoplastic disease. Cancer 1972; 30:761-773.
11. Flick MR, Cluff LE. Pseudomonas bacteremia. Review of 108 cases. Am J Med 1976; 60:501-508.
12. Balch AL, Griffin PE. Pseudomonas aeruginosa bacteremia: a clinical study of 75 patients. Am J Med Sci 1977; 274:119-129.
13. Tapper ML, Armstrong D. Bacteremia due to Pseudomonas aeruginosa complicating neoplastic disease: a progress report. J Infect Dis 1974; 130(Suppl):S14-S23.
14. Young LS. Gentamycin: clinical use with carbenicillin and in vitro studies with recent isolates of Pseudomonas aeruginosa. J Infect Dis 1971; 123(Suppl):S202-S205.
15. Schimpff SC, Greene WH, Young VM, et al. Pseudomonas septicemia: incidence, epidemiology, prevention, and therapy in patients with advanced cancer. Eur J Cancer 1973; 9:449-453.
16. Whitecar JP, Luna MA, Bodey GP. Pseudomonas bacteremia in patients with malignant diseases. Am J Med Sci 1970; 130:216-233.
17. Bennet JW. Nosocomial infections due to Pseudomonas. J Infect Dis 1974; 130:54-57.
18. Schimpff SC, Greene WH, Young VM, Wiernik PH. Significance of Pseudomonas aeruginosa in the patients with leukemia and lymphoma. J Infect Dis 1974; 130(Suppl):S24-S31.
19. Bustamante CI, Wade JC, Prada G, Schimpff SC. Pseudomonas aeruginosa bacteremias in neutropenic cancer patients. Proceedings of the 2nd International Symposium on Infections in Immunocompromised Hosts, Toronto, June 2-6, 1984.
20. Bodey GP, Jadeja L, Elting L. Pseudomonas bacteremia: retrospective analysis of 410 episodes. Arch Intern Med 1985; 145:1621-1629.
21. Kreger BE, Craven DE, Carling PC, McCabe WR. Gram-negative bacteremia. III. Reassessment of etiology, epidemiology, and ecology in 612 patients. Am J Med 1980; 68: 332-343.
22. Schimpff SC, Satterlee W, Young VM, et al. Empiric therapy with carbenicillin and gentamycin for febrile patients with cancer and granulocytopenia. N Engl J Med 1977; 284: 1061-1065.
23. Hovgaard D, Skinhoj P, Bangsborg J, Bruun B, Mork Hansen M, Nissen NI. Bacteremia and candidemia in hematological malignancies: clinical findings. Scand J Infect Dis 1988; 20:495-501.
24. Haug JB, Harthug S, Kalager T, et al. Bloodstream infection at a Norwegian university hospital, 1974-1979 and 1988-1989: changing etiology, clinical features, and outcome. Clin Infect Dis 1994; 19:245-256.
25. Cross A, Allen J, Burke J, Ducel G, Harris A, John J. Nosocomial infections due to Pseudomonas aeruginosa: review of recent trends. Rev Infect Dis 1983; 15(Suppl):S837-S845.
26. Gould IM, Wise R. Pseudomonas aeruginosa: clinical manifestations and management. Lancet 1985; ii:1224-1227.
27. Gatell JM, Trilla A, Latorre X, et al. Nosocomial bacteremia in a large Spanish teaching hospital: analysis of factor influencing prognosis. Rev Infect Dis 1988; 10:203-210.
28. Geerdes HF, Ziegler D, Lode H, et al. Septicemia in 980 patients at a university hospital in Berlin: prospective studies during four selected years between 1979 and 1989. Clin Infect Dis 1992; 15:991-1002.
29. Roberts FJ, Geere IW, Goldman A. A three-year study of positive blood cultures, with emphasis on prognosis. Rev Infect Dis 1991; 13:34-46.
30. Love LJ, Schimpff SC, Schiffer CA, Wiernik PH. Improved prognosis for granulocytopenic patients with gram-negative bacteremia. Am J Med 1980; 68:634-647.
31. Gill FA, Robinson R, MacLowry JG, Levine AS. The relationship of fever, granulocytopenia and antimicrobial therapy to bacteremia in cancer patients. Cancer 1977; 39:1704-1709.
32. Ziegler EJ, McCutchan JA, Fierer J, et al. Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 1979; 307:1225-1230.
33. Andriole VT. Pseudomonas bacteremia: Can antibiotic therapy improve survival? J Lab Clin Invest 1979; 94:196-200 (Editorial).
34. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64:328-340.
35. Gurwitz MJ, Brunton JL, Lank BA, Ronald AR, Harding GKM, McCulloch DW. Granulocytopenia in hospitalized patients. I. Prognostic factors and etiology of fever. Am J Med 1978; 64:121-126.
36. The EORTC International Antimicrobial Therapy Cooperative Group. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. N Engl J Med 1987; 317:1692-1698.
37. Pizzo PA, Hatorn JW, Heimenz J, et al. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 1986; 315:552-558.
38. Klastersky J, Meunier-Carpentier F, Prevost JM. Significance of antimicrobial synergism for the outcome of gram-negative sepsis. Am J Med Sci 1977; 273:157-167.
39. Elting LS, Rubenstein EB, Rolston KVJ, Bodey GP. Outcomes of bacteremia in patients with cancer and neutropenia: observation from two decades of epidemiological and clinical trials. Clin Infect Dis 1997; 25:247-259.
40. Funada H, Machi T, Matsuda T. Bacteremia complicating acute leukemia with special reference to its incidence and changing etiological patterns. Jpn J Clin Oncol 1988; 18:239-248.